Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron in combination with Apotel for pain control in upper limb fractures
IRCT2017062133566N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron and acetaminophen in upper extremity fracture and acute pain, sponsored by Golestan University of Medical Sciences. Started Aug 2017; status: completed.
02
Drugs
ondansetronacetaminophen
03
Conditions
upper extremity fractureacute pain
Beyond the preview
Go deeper on IRCT2017062133566N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017062133566N1.